Sporadic reports of JAK1 GOF variants with PIDD associated to autoimmunity or inflammation have significantly advanced our understanding of the molecular mechanisms underlying JAK/STAT activation, which is key for guiding targeted therapies (Ott et al, 2023). The gene discussed is JAK1; the disease is Autoimmunity.